160 related articles for article (PubMed ID: 6216288)
21. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
22. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
[TBL] [Abstract][Full Text] [Related]
23. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells.
von Boehmer H; Hafen K
Nature; 1986 Apr 17-23; 320(6063):626-8. PubMed ID: 3486368
[TBL] [Abstract][Full Text] [Related]
24. Differential susceptibility of cytotoxic and helper T cell precursors to neonatal tolerization to histocompatibility antigens.
Ishizaka ST; Carnaud C; Stutman O
J Immunol; 1986 Oct; 137(7):2093-9. PubMed ID: 2944947
[TBL] [Abstract][Full Text] [Related]
25. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
26. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
Kosmatopoulos K; Algara DS; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
[TBL] [Abstract][Full Text] [Related]
27. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
28. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
Good MF; Nossal GJ
J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
[TBL] [Abstract][Full Text] [Related]
29. Soluble suppressor of T cell proliferation in primary in vitro response to murine minor histocompatibility antigens.
Solana R; Alonso MC; de la Fuente M; Alonso A; Peña J
Rev Esp Fisiol; 1984 Sep; 40(3):341-52. PubMed ID: 6240742
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
[TBL] [Abstract][Full Text] [Related]
31. Nonresponsiveness to the male antigen H-Y in H-2 I-A-mutant B6.C-H-2bm12 is not caused by defective antigen presentation.
de Waal LP; de Hoop J; Stukart MJ; Gleichmann H; Melvold RW; Melief CJ
J Immunol; 1983 Feb; 130(2):655-60. PubMed ID: 6401303
[TBL] [Abstract][Full Text] [Related]
32. Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function.
Gautam SC; Battisto JR
Reg Immunol; 1989; 2(1):33-41. PubMed ID: 2534947
[TBL] [Abstract][Full Text] [Related]
33. The role of T cell subsets in the generation of secondary cytolytic responses in vitro against class I and class II major histocompatibility complex antigens.
Vidović D; Klein J; Nagy ZA
J Immunol; 1984 Mar; 132(3):1113-7. PubMed ID: 6229577
[TBL] [Abstract][Full Text] [Related]
34. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
Gorczynski RM; Macrae S
Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
[TBL] [Abstract][Full Text] [Related]
35. Induction of CTL responses to alloantigens by a Db-specific T helper clone.
Kwong PC; Kilburn DG; Teh HS
J Immunol; 1984 Aug; 133(2):653-9. PubMed ID: 6203972
[TBL] [Abstract][Full Text] [Related]
36. Primary T-cell responses to minor alloantigens. II. Analysis of accessory cell requirements for the development of cytotoxic T lymphocytes.
Czitrom AA; Liddell M
Immunology; 1983 Dec; 50(4):555-63. PubMed ID: 6228514
[TBL] [Abstract][Full Text] [Related]
37. Induction of early alloantigen tolerance in thymus and spleen.
Schwartz DH; Doherty PC
Thymus; 1984; 6(1-2):105-20. PubMed ID: 6235644
[TBL] [Abstract][Full Text] [Related]
38. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
39. Detection in vivo 6 hours after immunization of a mediator with possible antisuppressor activity.
Maghazachi AA; Lee ST; Paraskevas F
Eur J Immunol; 1983 Oct; 13(10):799-804. PubMed ID: 6227487
[TBL] [Abstract][Full Text] [Related]
40. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
